A Study of HNC042 in Healthy Chinese Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics

NCT04603989 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

DRUG: HNC042 for Injection
DRUG: Placebo Comparator

Sponsor

Guangzhou Henovcom Bioscience Co. Ltd.

Collaborators

[object Object]